In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Neurologic Disorders Therapeuticsin a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Neurologic Disorders Therapeuticsmarket covered in Chapter 13:
Alltech Inc.
Cargill Inc.
Pancosma SA
Kemin Industries Inc.
Also read: http://www.marketwatch.com/story/loan-servicing-software-market-res...
Mercer Milling Co. Inc.
Nutreco NV
Bio Multimin Inc.
Novus International Inc.
Archer Daniels Midland Co.
In Chapter 6, on the basis of types, the Neurologic Disorders Therapeuticsmarket from 2015 to 2025 is primarily split into:
Vitamin A
Vitamin B
Vitamin C
Vitamin E
Other Vitamins
Also read: http://www.marketwatch.com/story/june-2021-report-on-global-christm...
Europe
China
Japan
India
Also read: http://www.marketwatch.com/story/june-2021-report-on-global-intelli...
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
Also read: http://www.marketwatch.com/story/june-2021-report-on-global-inorgan...
Table of content
1 Neurologic Disorders TherapeuticsMarket - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 Neurologic Disorders TherapeuticsMarket - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
3 Neurologic Disorders TherapeuticsMarket Forces
3.1 Global Neurologic Disorders TherapeuticsMarket Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment
4 Neurologic Disorders TherapeuticsMarket - By Geography
4.1 Global Neurologic Disorders TherapeuticsMarket Value and Market Share by Regions
4.1.1 Global Neurologic Disorders TherapeuticsValue ($) by Region (2015-2020)
4.1.2 Global Neurologic Disorders TherapeuticsValue Market Share by Regions (2015-2020)
4.2 Global Neurologic Disorders TherapeuticsMarket Production and Market Share by Major Countries
4.2.1 Global Neurologic Disorders TherapeuticsProduction by Major Countries (2015-2020)
4.2.2 Global Neurologic Disorders TherapeuticsProduction Market Share by Major Countries (2015-2020)
4.3 Global Neurologic Disorders TherapeuticsMarket Consumption and Market Share by Regions
4.3.1 Global Neurologic Disorders TherapeuticsConsumption by Regions (2015-2020)
4.3.2 Global Neurologic Disorders TherapeuticsConsumption Market Share by Regions (2015-2020)
5 Neurologic Disorders TherapeuticsMarket - By Trade Statistics
5.1 Global Neurologic Disorders TherapeuticsExport and Import
5.2 United States Neurologic Disorders TherapeuticsExport and Import (2015-2020)
5.3 Europe Neurologic Disorders TherapeuticsExport and Import (2015-2020)
5.4 China Neurologic Disorders TherapeuticsExport and Import (2015-2020)
5.5 Japan Neurologic Disorders TherapeuticsExport and Import (2015-2020)
5.6 India Neurologic Disorders TherapeuticsExport and Import (2015-2020)
5.7 ...
6 Neurologic Disorders TherapeuticsMarket - By Type
6.1 Global Neurologic Disorders TherapeuticsProduction and Market Share by Types (2015-2020)
6.1.1 Global Neurologic Disorders TherapeuticsProduction by Types (2015-2020)
6.1.2 Global Neurologic Disorders TherapeuticsProduction Market Share by Types (2015-2020)
6.2 Global Neurologic Disorders TherapeuticsValue and Market Share by Types (2015-2020)
6.2.1 Global Neurologic Disorders TherapeuticsValue by Types (2015-2020)
6.2.2 Global Neurologic Disorders TherapeuticsValue Market Share by Types (2015-2020)
6.3 Global Neurologic Disorders TherapeuticsProduction, Price and Growth Rate of Vitamin A (2015-2020)
6.4 Global Neurologic Disorders TherapeuticsProduction, Price and Growth Rate of Vitamin B (2015-2020)
6.5 Global Neurologic Disorders TherapeuticsProduction, Price and Growth Rate of Vitamin C (2015-2020)
6.6 Global Neurologic Disorders TherapeuticsProduction, Price and Growth Rate of Vitamin E (2015-2020)
6.7 Global Neurologic Disorders TherapeuticsProduction, Price and Growth Rate of Other Vitamins (2015-2020)
7 Neurologic Disorders TherapeuticsMarket - By Application
7.1 Global Neurologic Disorders TherapeuticsConsumption and Market Share by Applications (2015-2020)
7.1.1 Global Neurologic Disorders TherapeuticsConsumption by Applications (2015-2020)
7.1.2 Global Neurologic Disorders TherapeuticsConsumption Market Share by Applications (2015-2020)
7.2 Global Neurologic Disorders TherapeuticsConsumption and Growth Rate of Ruminant (2015-2020)
7.3 Global Neurologic Disorders TherapeuticsConsumption and Growth Rate of Poultry (2015-2020)
7.4 Global Neurologic Disorders TherapeuticsConsumption and Growth Rate of Swine (2015-2020)
7.5 Global Neurologic Disorders TherapeuticsConsumption and Growth Rate of Aquaculture (2015-2020)
7.6 Global Neurologic Disorders TherapeuticsConsumption and Growth Rate of Others (2015-2020)
Also read: http://www.marketwatch.com/story/june-2021-report-on-global-halophy...
9 Europe Neurologic Disorders TherapeuticsMarket Analysis
9.1 Europe Neurologic Disorders TherapeuticsMarket Size
9.2 Germany Neurologic Disorders TherapeuticsMarket Size
9.3 United Kingdom Neurologic Disorders TherapeuticsMarket Size
9.4 France Neurologic Disorders TherapeuticsMarket Size
9.5 Italy Neurologic Disorders TherapeuticsMarket Size
9.6 Spain Neurologic Disorders TherapeuticsMarket Size
9.7 The Influence of COVID-19 on Europe Market
10 Asia-Pacific Neurologic Disorders TherapeuticsMarket Analysis
10.1 Asia-Pacific Neurologic Disorders TherapeuticsMarket Size
10.2 China Neurologic Disorders TherapeuticsMarket Size
10.3 Japan Neurologic Disorders TherapeuticsMarket Size
10.4 South Korea Neurologic Disorders TherapeuticsMarket Size
10.5 Southeast Asia Neurologic Disorders TherapeuticsMarket Size
10.6 India Neurologic Disorders TherapeuticsMarket Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 Middle East and Africa Neurologic Disorders TherapeuticsMarket Analysis
11.1 Middle East and Africa Neurologic Disorders TherapeuticsMarket Size
11.2 Saudi Arabia Neurologic Disorders TherapeuticsMarket Size
11.3 UAE Neurologic Disorders TherapeuticsMarket Size
11.4 South Africa Neurologic Disorders TherapeuticsMarket Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 South America Neurologic Disorders TherapeuticsMarket Analysis
12.1 South America Neurologic Disorders TherapeuticsMarket Size
12.2 Brazil Neurologic Disorders TherapeuticsMarket Size
12.3 The Influence of COVID-19 on South America Market
13 Company Profiles
13.1 Alltech Inc.
13.1.1 Alltech Inc. Basic Information
13.1.2 Alltech Inc. Product Profiles, Application and Specification
13.1.3 Alltech Inc. Neurologic Disorders TherapeuticsMarket Performance (2015-2020)
13.2 Cargill Inc.
13.2.1 Cargill Inc. Basic Information
13.2.2 Cargill Inc. Product Profiles, Application and Specification
13.2.3 Cargill Inc. Neurologic Disorders TherapeuticsMarket Performance (2015-2020)
13.3 Pancosma SA
13.3.1 Pancosma SA Basic Information
13.3.2 Pancosma SA Product Profiles, Application and Specification
13.3.3 Pancosma SA Neurologic Disorders TherapeuticsMarket Performance (2015-2020)
13.4 Kemin Industries Inc.
13.4.1 Kemin Industries Inc. Basic Information
13.4.2 Kemin Industries Inc. Product Profiles, Application and Specification
13.4.3 Kemin Industries Inc. Neurologic Disorders TherapeuticsMarket Performance (2015-2020)
13.5 Davidsons Animal Feeds
13.5.1 Davidsons Animal Feeds Basic Information
13.5.2 Davidsons Animal Feeds Product Profiles, Application and Specification
13.5.3 Davidsons Animal Feeds Neurologic Disorders TherapeuticsMarket Performance (2015-2020)
13.6 Biochem Lohne Germany
13.6.1 Biochem Lohne Germany Basic Information
13.6.2 Biochem Lohne Germany Product Profiles, Application and Specification
13.6.3 Biochem Lohne Germany Neurologic Disorders TherapeuticsMarket Performance (2015-2020)
13.7 Mercer Milling Co. Inc.
13.7.1 Mercer Milling Co. Inc. Basic Information
13.7.2 Mercer Milling Co. Inc. Product Profiles, Application and Specification
13.7.3 Mercer Milling Co. Inc. Neurologic Disorders TherapeuticsMarket Performance (2015-2020)
13.8 Nutreco NV
13.8.1 Nutreco NV Basic Information
13.8.2 Nutreco NV Product Profiles, Application and Specification
13.8.3 Nutreco NV Neurologic Disorders TherapeuticsMarket Performance (2015-2020)
13.9 Bio Multimin Inc.
13.9.1 Bio Multimin Inc. Basic Information
13.9.2 Bio Multimin Inc. Product Profiles, Application and Specification
13.9.3 Bio Multimin Inc. Neurologic Disorders TherapeuticsMarket Performance (2015-2020)
13.10 Novus International Inc.
13.10.1 Novus International Inc. Basic Information
13.10.2 Novus International Inc. Product Profiles, Application and Specification
13.10.3 Novus International Inc. Neurologic Disorders TherapeuticsMarket Performance (2015-2020)
13.11 Archer Daniels Midland Co.
13.11.1 Archer Daniels Midland Co. Basic Information
13.11.2 Archer Daniels Midland Co. Product Profiles, Application and Specification
13.11.3 Archer Daniels Midland Co. Neurologic Disorders TherapeuticsMarket Performance (2015-2020)
14 Market Forecast - By Regions
14.1 North America Neurologic Disorders TherapeuticsMarket Forecast (2020-2025)
14.2 Europe Neurologic Disorders TherapeuticsMarket Forecast (2020-2025)
14.3 Asia-Pacific Neurologic Disorders TherapeuticsMarket Forecast (2020-2025)
14.4 Middle East and Africa Neurologic Disorders TherapeuticsMarket Forecast (2020-2025)
14.5 South America Neurologic Disorders TherapeuticsMarket Forecast (2020-2025)
15 Market Forecast - By Type and Applications
15.1 Global Neurologic Disorders TherapeuticsMarket Forecast by Types (2020-2025)
15.1.1 Global Neurologic Disorders TherapeuticsMarket Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Neurologic Disorders TherapeuticsMarket Forecast Value and Market Share by Types (2020-2025)
15.2 Global Neurologic Disorders TherapeuticsMarket Forecast by Applications (2020-2025)
List of Tables and Figures
Figure Neurologic Disorders TherapeuticsPicture
Table Neurologic Disorders TherapeuticsKey Market Segments
Figure Study and Forecasting Years
Figure Global Neurologic Disorders TherapeuticsMarket Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Neurologic Disorders TherapeuticsValue ($) and Growth Rate (2015-2020)
Table Global Neurologic Disorders TherapeuticsValue ($) by Countries (2015-2020)
Table Global Neurologic Disorders TherapeuticsValue Market Share by Regions (2015-2020)
……. continued
CONTACT DETAILS :
[email protected]
+44 203 500 2763
+1 62 825 80070
971 0503084105